688091 Shanghai Yizhong Pharmaceutical
- 38.41
- -1.11-2.81%
Shanghai Yizhong Pharmaceutical News
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the 2023 profit distribution and capital reserve transfer plan
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the 2024 remuneration plan for directors, supervisors and senior management
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on renewing the employment of an accounting firm
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on revising and adding some corporate governance systems
Audit Committee Implementation Rules (April 2024)
Board of Directors Rules of Procedure (April 2024)
Special meeting system for independent directors
Related transaction management system
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on matters relating to the adjustment of the 2022 restricted stock incentive plan
Announcement of Resolutions of the Fourth Meeting of the 2nd Board of Supervisors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. and its subsidiaries on the use of idle own funds for cash management
Special Report on the Deposit and Use of Funds Raised by Shanghai Yizhong Pharmaceutical Co., Ltd. in 2023
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the by-election of independent directors of the second board of directors of the company and the adjustment of the board special committee
Independent Director Candidate Statement_Zhou Aiwu
Independent Director Nominee Statement
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on amending the company's articles of association
Articles of Association of Shanghai Yizhong Company (April 2024)
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on meeting the eligibility requirements for the first vesting period of the 2022 Restricted Stock Incentive Plan
The supervisory board's review opinion on the list of incentive recipients
Legal Opinion of Shanghai AllBright Law Firm on matters relating to the first vesting period of the 2022 Restricted Stock Incentive Plan of Shanghai Yizhong Pharmaceutical Co., Ltd. meeting the conditions of ownership and the adjustment of the 2022 Restric
Analysis
Price Target
No Data
